|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (11) | Number of the document | 1218009 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00960855.5 |
| Date of filing the European patent application | 2000-09-18 | |
| (97) | Date of publication of the European application | 2002-07-03 |
| (45) | Date of publication and mention of the grant of the patent | 2005-02-02 |
| (46) | Date of publication of the claims translation | 2005-05-25 |
| (86) | Number | PCT/GB2000/003598 |
| Date | 2000-09-18 |
| (87) | Number | WO 2001/021179 |
| Date | 2001-03-29 |
| (30) | Number | Date | Country code |
| 9922271 | 1999-09-21 | GB |
| (72) |
BROWN, Daniel, Boyd, US
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Kvatiapino granulės |
| QUETIAPINE GRANULES |
| Payment date | Validity (years) | Amount | |
| 2015-09-07 | 16 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2016-09-18 |